Selected research
Industry Research
OTC Cough and Cold and Allergy Medicine Industry Research Report 2026
Market perspective
The global OTC Cough and Cold and Allergy Medicine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for OTC Cough and Cold and Allergy Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for OTC Cough and Cold and Allergy Medicine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for OTC Cough and Cold and Allergy Medicine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of OTC Cough and Cold and Allergy Medicine include Allergen, AstraZaneca, Bristol-Myers Squib, Prestige Brands Holdings, Procter and Gamble, Reckitt Benckiser Group, Sanofi-Aventis, GlaxoSmithKline and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global OTC Cough and Cold and Allergy Medicine market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
OTC Cough and Cold and Allergy Medicine Market by Company
Allergen
AstraZaneca
Bristol-Myers Squib
Prestige Brands Holdings
Procter and Gamble
Reckitt Benckiser Group
Sanofi-Aventis
GlaxoSmithKline
Pfizer
Merck and Co.
Novartis
Johnson and Johnson
Sun Pharmaceutical Industries
OTC Cough and Cold and Allergy Medicine Segment by Type
Antibiotics
Antihistamine
Expectorants
Bronchodialators
Others
OTC Cough and Cold and Allergy Medicine Segment by Application
Online
Offline
OTC Cough and Cold and Allergy Medicine Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global OTC Cough and Cold and Allergy Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of OTC Cough and Cold and Allergy Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of OTC Cough and Cold and Allergy Medicine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of OTC Cough and Cold and Allergy Medicine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of OTC Cough and Cold and Allergy Medicine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of OTC Cough and Cold and Allergy Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Antibiotics
- Antihistamine
- Expectorants
- Bronchodialators
- Others
Applications
- Online
- Offline
Companies covered
- Allergen
- AstraZaneca
- Bristol-Myers Squib
- Prestige Brands Holdings
- Procter and Gamble
- Reckitt Benckiser Group
- Sanofi-Aventis
- GlaxoSmithKline
- Pfizer
- Merck and Co.
- Novartis
- Johnson and Johnson
- Sun Pharmaceutical Industries
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global OTC Cough and Cold and Allergy Medicine Market Size (2021-2032)
- 2.2.2 Global OTC Cough and Cold and Allergy Medicine Sales (2021-2032)
- 2.2.3 Global OTC Cough and Cold and Allergy Medicine Market Average Price (2021-2032)
- 2.3 OTC Cough and Cold and Allergy Medicine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Antibiotics
- 2.3.3 Antihistamine
- 2.3.4 Expectorants
- 2.3.5 Bronchodialators
- 2.3.6 Others
- 2.4 OTC Cough and Cold and Allergy Medicine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Online
- 2.4.3 Offline
3 Market Competitive Landscape by Manufacturers
- 3.1 Global OTC Cough and Cold and Allergy Medicine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global OTC Cough and Cold and Allergy Medicine Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global OTC Cough and Cold and Allergy Medicine Revenue of Manufacturers (2021-2026)
- 3.4 Global OTC Cough and Cold and Allergy Medicine Average Price by Manufacturers (2021-2026)
- 3.5 Global OTC Cough and Cold and Allergy Medicine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of OTC Cough and Cold and Allergy Medicine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of OTC Cough and Cold and Allergy Medicine, Product Type & Application
- 3.8 Global Manufacturers of OTC Cough and Cold and Allergy Medicine, Established Date
- 3.9 Global OTC Cough and Cold and Allergy Medicine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Allergen
- 4.1.1 Allergen Company Information
- 4.1.2 Allergen Business Overview
- 4.1.3 Allergen OTC Cough and Cold and Allergy Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Allergen OTC Cough and Cold and Allergy Medicine Product Portfolio
- 4.1.5 Allergen Recent Developments
- 4.2 AstraZaneca
- 4.2.1 AstraZaneca Company Information
- 4.2.2 AstraZaneca Business Overview
- 4.2.3 AstraZaneca OTC Cough and Cold and Allergy Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 AstraZaneca OTC Cough and Cold and Allergy Medicine Product Portfolio
- 4.2.5 AstraZaneca Recent Developments
- 4.3 Bristol-Myers Squib
- 4.3.1 Bristol-Myers Squib Company Information
- 4.3.2 Bristol-Myers Squib Business Overview
- 4.3.3 Bristol-Myers Squib OTC Cough and Cold and Allergy Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Bristol-Myers Squib OTC Cough and Cold and Allergy Medicine Product Portfolio
- 4.3.5 Bristol-Myers Squib Recent Developments
- 4.4 Prestige Brands Holdings
- 4.4.1 Prestige Brands Holdings Company Information
- 4.4.2 Prestige Brands Holdings Business Overview
- 4.4.3 Prestige Brands Holdings OTC Cough and Cold and Allergy Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Prestige Brands Holdings OTC Cough and Cold and Allergy Medicine Product Portfolio
- 4.4.5 Prestige Brands Holdings Recent Developments
- 4.5 Procter and Gamble
- 4.5.1 Procter and Gamble Company Information
- 4.5.2 Procter and Gamble Business Overview
- 4.5.3 Procter and Gamble OTC Cough and Cold and Allergy Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Procter and Gamble OTC Cough and Cold and Allergy Medicine Product Portfolio
- 4.5.5 Procter and Gamble Recent Developments
- 4.6 Reckitt Benckiser Group
- 4.6.1 Reckitt Benckiser Group Company Information
- 4.6.2 Reckitt Benckiser Group Business Overview
- 4.6.3 Reckitt Benckiser Group OTC Cough and Cold and Allergy Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Reckitt Benckiser Group OTC Cough and Cold and Allergy Medicine Product Portfolio
- 4.6.5 Reckitt Benckiser Group Recent Developments
- 4.7 Sanofi-Aventis
- 4.7.1 Sanofi-Aventis Company Information
- 4.7.2 Sanofi-Aventis Business Overview
- 4.7.3 Sanofi-Aventis OTC Cough and Cold and Allergy Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Sanofi-Aventis OTC Cough and Cold and Allergy Medicine Product Portfolio
- 4.7.5 Sanofi-Aventis Recent Developments
- 4.8 GlaxoSmithKline
- 4.8.1 GlaxoSmithKline Company Information
- 4.8.2 GlaxoSmithKline Business Overview
- 4.8.3 GlaxoSmithKline OTC Cough and Cold and Allergy Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 GlaxoSmithKline OTC Cough and Cold and Allergy Medicine Product Portfolio
- 4.8.5 GlaxoSmithKline Recent Developments
- 4.9 Pfizer
- 4.9.1 Pfizer Company Information
- 4.9.2 Pfizer Business Overview
- 4.9.3 Pfizer OTC Cough and Cold and Allergy Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Pfizer OTC Cough and Cold and Allergy Medicine Product Portfolio
- 4.9.5 Pfizer Recent Developments
- 4.10 Merck and Co.
- 4.10.1 Merck and Co. Company Information
- 4.10.2 Merck and Co. Business Overview
- 4.10.3 Merck and Co. OTC Cough and Cold and Allergy Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Merck and Co. OTC Cough and Cold and Allergy Medicine Product Portfolio
- 4.10.5 Merck and Co. Recent Developments
- 4.11 Novartis
- 4.11.1 Novartis Company Information
- 4.11.2 Novartis Business Overview
- 4.11.3 Novartis OTC Cough and Cold and Allergy Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Novartis OTC Cough and Cold and Allergy Medicine Product Portfolio
- 4.11.5 Novartis Recent Developments
- 4.12 Johnson and Johnson
- 4.12.1 Johnson and Johnson Company Information
- 4.12.2 Johnson and Johnson Business Overview
- 4.12.3 Johnson and Johnson OTC Cough and Cold and Allergy Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Johnson and Johnson OTC Cough and Cold and Allergy Medicine Product Portfolio
- 4.12.5 Johnson and Johnson Recent Developments
- 4.13 Sun Pharmaceutical Industries
- 4.13.1 Sun Pharmaceutical Industries Company Information
- 4.13.2 Sun Pharmaceutical Industries Business Overview
- 4.13.3 Sun Pharmaceutical Industries OTC Cough and Cold and Allergy Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Sun Pharmaceutical Industries OTC Cough and Cold and Allergy Medicine Product Portfolio
- 4.13.5 Sun Pharmaceutical Industries Recent Developments
5 Global OTC Cough and Cold and Allergy Medicine Market Scenario by Region
- 5.1 Global OTC Cough and Cold and Allergy Medicine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global OTC Cough and Cold and Allergy Medicine Sales by Region: 2021-2032
- 5.2.1 Global OTC Cough and Cold and Allergy Medicine Sales by Region: 2021-2026
- 5.2.2 Global OTC Cough and Cold and Allergy Medicine Sales by Region: 2027-2032
- 5.3 Global OTC Cough and Cold and Allergy Medicine Revenue by Region: 2021-2032
- 5.3.1 Global OTC Cough and Cold and Allergy Medicine Revenue by Region: 2021-2026
- 5.3.2 Global OTC Cough and Cold and Allergy Medicine Revenue by Region: 2027-2032
- 5.4 North America OTC Cough and Cold and Allergy Medicine Market Facts & Figures by Country
- 5.4.1 North America OTC Cough and Cold and Allergy Medicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America OTC Cough and Cold and Allergy Medicine Sales by Country (2021-2032)
- 5.4.3 North America OTC Cough and Cold and Allergy Medicine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe OTC Cough and Cold and Allergy Medicine Market Facts & Figures by Country
- 5.5.1 Europe OTC Cough and Cold and Allergy Medicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe OTC Cough and Cold and Allergy Medicine Sales by Country (2021-2032)
- 5.5.3 Europe OTC Cough and Cold and Allergy Medicine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific OTC Cough and Cold and Allergy Medicine Market Facts & Figures by Country
- 5.6.1 Asia Pacific OTC Cough and Cold and Allergy Medicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific OTC Cough and Cold and Allergy Medicine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific OTC Cough and Cold and Allergy Medicine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America OTC Cough and Cold and Allergy Medicine Market Facts & Figures by Country
- 5.7.1 South America OTC Cough and Cold and Allergy Medicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America OTC Cough and Cold and Allergy Medicine Sales by Country (2021-2032)
- 5.7.3 South America OTC Cough and Cold and Allergy Medicine Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa OTC Cough and Cold and Allergy Medicine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa OTC Cough and Cold and Allergy Medicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa OTC Cough and Cold and Allergy Medicine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa OTC Cough and Cold and Allergy Medicine Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global OTC Cough and Cold and Allergy Medicine Sales by Type (2021-2032)
- 6.1.1 Global OTC Cough and Cold and Allergy Medicine Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global OTC Cough and Cold and Allergy Medicine Sales Market Share by Type (2021-2032)
- 6.2 Global OTC Cough and Cold and Allergy Medicine Revenue by Type (2021-2032)
- 6.2.1 Global OTC Cough and Cold and Allergy Medicine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global OTC Cough and Cold and Allergy Medicine Revenue Market Share by Type (2021-2032)
- 6.3 Global OTC Cough and Cold and Allergy Medicine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global OTC Cough and Cold and Allergy Medicine Sales by Application (2021-2032)
- 7.1.1 Global OTC Cough and Cold and Allergy Medicine Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global OTC Cough and Cold and Allergy Medicine Sales Market Share by Application (2021-2032)
- 7.2 Global OTC Cough and Cold and Allergy Medicine Revenue by Application (2021-2032)
- 7.2.1 Global OTC Cough and Cold and Allergy Medicine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global OTC Cough and Cold and Allergy Medicine Revenue Market Share by Application (2021-2032)
- 7.3 Global OTC Cough and Cold and Allergy Medicine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 OTC Cough and Cold and Allergy Medicine Value Chain Analysis
- 8.1.1 OTC Cough and Cold and Allergy Medicine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 OTC Cough and Cold and Allergy Medicine Production Mode & Process
- 8.2 OTC Cough and Cold and Allergy Medicine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 OTC Cough and Cold and Allergy Medicine Distributors
- 8.2.3 OTC Cough and Cold and Allergy Medicine Customers
9 Global OTC Cough and Cold and Allergy Medicine Analyzing Market Dynamics
- 9.1 OTC Cough and Cold and Allergy Medicine Industry Trends
- 9.2 OTC Cough and Cold and Allergy Medicine Industry Drivers
- 9.3 OTC Cough and Cold and Allergy Medicine Industry Opportunities and Challenges
- 9.4 OTC Cough and Cold and Allergy Medicine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst